Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On

Content Curator
In this May 2020 file photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Monday, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn

The trial studied the efficacy of bamlanivimab and remdesivir on hospitalized COVID-19 patients - the same therapies given to President Trump. But researchers say people showed no marked improvement.

(Image credit: David Morrison/AP)